Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry 'Revision: v3.6.3' appears in the study history, indicating an internal page update. The visible study information and layout appear unchanged.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now shows that the study is no longer actively recruiting participants, reflecting a change in recruitment status. It also adds a new release version v3.6.0 and removes the previous version v3.5.5 from the history.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page history shows a new release label, 'Revision: v3.5.5', indicating a system update to the page; the previous revision label 'Revision: v3.5.4' appears to be replaced in the history metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's software version was updated from v3.5.3 to v3.5.4. This indicates a newer release of the site's record-history UI and related components.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page’s display footer revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a maintenance or release update for the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check85 days agoChange DetectedReplimune, Inc. was added and Replimune Inc. was removed. Revision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.2%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.